Xenon Pharmaceuticals (NASDAQ:XENE) Posts Earnings Results, Beats Estimates By $0.01 EPS

Xenon Pharmaceuticals (NASDAQ:XENE – Get Free Report) released its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($0.81) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.82) by $0.01, Briefing.com reports. During the same period in the prior year, the company earned ($0.73) earnings per share. Xenon Pharmaceuticals Stock Down […]

Leave a Reply

Your email address will not be published.

Previous post MQS Management LLC Lowers Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Next post Novavax (NASDAQ:NVAX) Posts Earnings Results, Beats Expectations By $0.11 EPS